Advances in chitosan-based hydrogels for pharmaceutical and biomedical applications : A comprehensive review
Copyright © 2023 Elsevier B.V. All rights reserved..
The treatment of diseases, such as cancer, is one of the most significant issues correlated with human beings health. Hydrogels (HGs) prepared from biocompatible and biodegradable materials, especially biopolymers, have been effectively employed for the sort of pharmaceutical and biomedical applications, including drug delivery systems, biosensors, and tissue engineering. Chitosan (CS), one of the most abundant bio-polysaccharide derived from chitin, is an efficient biomaterial in the prognosis, diagnosis, and treatment of diseases. CS-based HGs possess some potential advantages, like high values of bioactive encapsulation, efficient drug delivery to a target site, sustained drug release, good biocompatibility and biodegradability, high serum stability, non-immunogenicity, etc., which made them practical and useful for pharmaceutical and biomedical applications. In this review, we summarize recent achievements and advances associated with CS-based HGs for drug delivery, regenerative medicine, disease detection and therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:253 |
|---|---|
| Enthalten in: |
International journal of biological macromolecules - 253(2023), Pt 6 vom: 31. Dez., Seite 127278 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Almajidi, Yasir Qasim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9012-76-4 |
|---|
| Anmerkungen: |
Date Completed 23.11.2023 Date Revised 23.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijbiomac.2023.127278 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363000011 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363000011 | ||
| 003 | DE-627 | ||
| 005 | 20231226092421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijbiomac.2023.127278 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM363000011 | ||
| 035 | |a (NLM)37806412 | ||
| 035 | |a (PII)S0141-8130(23)04175-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almajidi, Yasir Qasim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advances in chitosan-based hydrogels for pharmaceutical and biomedical applications |b A comprehensive review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.11.2023 | ||
| 500 | |a Date Revised 23.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
| 520 | |a The treatment of diseases, such as cancer, is one of the most significant issues correlated with human beings health. Hydrogels (HGs) prepared from biocompatible and biodegradable materials, especially biopolymers, have been effectively employed for the sort of pharmaceutical and biomedical applications, including drug delivery systems, biosensors, and tissue engineering. Chitosan (CS), one of the most abundant bio-polysaccharide derived from chitin, is an efficient biomaterial in the prognosis, diagnosis, and treatment of diseases. CS-based HGs possess some potential advantages, like high values of bioactive encapsulation, efficient drug delivery to a target site, sustained drug release, good biocompatibility and biodegradability, high serum stability, non-immunogenicity, etc., which made them practical and useful for pharmaceutical and biomedical applications. In this review, we summarize recent achievements and advances associated with CS-based HGs for drug delivery, regenerative medicine, disease detection and therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biosensors | |
| 650 | 4 | |a Chitosan hydrogels | |
| 650 | 4 | |a Disease therapy | |
| 650 | 4 | |a Pharmaceutical application | |
| 650 | 4 | |a Preparation and modification | |
| 650 | 4 | |a Regenerative medicine | |
| 650 | 7 | |a Chitosan |2 NLM | |
| 650 | 7 | |a 9012-76-4 |2 NLM | |
| 650 | 7 | |a Hydrogels |2 NLM | |
| 650 | 7 | |a Biocompatible Materials |2 NLM | |
| 700 | 1 | |a Gupta, Jitendra |e verfasserin |4 aut | |
| 700 | 1 | |a Sheri, Fatime Satar |e verfasserin |4 aut | |
| 700 | 1 | |a Zabibah, Rahman S |e verfasserin |4 aut | |
| 700 | 1 | |a Faisal, Ahmed |e verfasserin |4 aut | |
| 700 | 1 | |a Ruzibayev, Akbarali |e verfasserin |4 aut | |
| 700 | 1 | |a Adil, Mohaned |e verfasserin |4 aut | |
| 700 | 1 | |a Saadh, Mohamed J |e verfasserin |4 aut | |
| 700 | 1 | |a Jawad, Mahmood Jasem |e verfasserin |4 aut | |
| 700 | 1 | |a Alsaikhan, Fahad |e verfasserin |4 aut | |
| 700 | 1 | |a Narmani, Asghar |e verfasserin |4 aut | |
| 700 | 1 | |a Farhood, Bagher |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 253(2023), Pt 6 vom: 31. Dez., Seite 127278 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
| 773 | 1 | 8 | |g volume:253 |g year:2023 |g number:Pt 6 |g day:31 |g month:12 |g pages:127278 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2023.127278 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 253 |j 2023 |e Pt 6 |b 31 |c 12 |h 127278 | ||